October's Life Sciences edition: AstraZeneca's $1.5bn reshaping, GSK's Belgian cuts and record-low Q3 layoffs, plus a three-pillar board view of five...
September's Life Sciences edition: ABPI's UK talent warning, GSK's Dresden closure plan and August's low layoff count, plus where peers' AI skills...
August's Life Sciences edition: Pfizer's extra $2.5bn of savings, rising job postings and Sanofi's Blueprint move, plus how peers' leadership scores...
July's Life Sciences edition: the UK Sector Plan's £3bn year, Novartis's fourth New Jersey cut and H1 layoffs, plus half-year turnover across six...
June's Life Sciences edition: May's near-7,000 job cuts, a slow hiring outlook and Merck's next phase, plus how work-life balance compares across...
May 2026 for Life Sciences HR: Sanofi's 50 AI roles, Novartis's Wehr closure, the FT's UK Best Employers and AI skills benchmarks across sector peers.
April 2026 for Life Sciences HR: fewer but bigger layoffs, Boehringer's London AI hub, contract hiring and Agility & Bureaucracy benchmarks across...
March 2026 for Life Sciences HR: the job-switch pay premium, bonuses up 24%, Takeda's restructuring and Pay & Rewards benchmarks across ten sector...
February 2026 for Life Sciences HR: GSK's new CEO agenda, Stevenage R&D cuts, a tighter jobs market and Supportive Leadership benchmarks across ten...
January 2026 for Life Sciences HR: Takeda redeploys, Lilly adds 850 jobs, AstraZeneca grows in China, plus sector culture, workforce and talent...